| Elizabeth (Betsy) Hirsch|
Department: Department of Pharmacy Practice
Department 2: School of Pharmacy
Office: 140 The Fenway, R219
B.S. in Health Sciences, Creighton University, Omaha, NE
Pharm.D., Creighton University, Omaha, NE
PGY1 Pharmacy Practice Residency, St. Luke’s Episcopal Hospital, Houston, TX
Infectious Diseases Pharmacotherapy Fellowship, University of Houston and St. Luke’s Episcopal Hospital, Houston, TX
Certification: Board Certified Pharmacotherapy Specialist
Specializations: infectious diseases
Research Interests: antimicrobial pharmacokinetics/pharmacodynamics, mechanisms of bacterial resistance
Hirsch EB, Cottreau JM, Ikwuagwu JO, Lusardi KT, Mohr JF, Rodriguez SM, Shah DN, Tran TT, on behalf of the Houston Infectious Diseases Network. Significant publications in infectious diseases pharmacotherapy in 2010. Accepted for publication May 31, 2011.
Hirsch EB, Chang KT, Lasco TM, Caeiro JP, Tam VH. Emergence of KPC-producing Klebsiella pneumoniae (KPC-Kp) in Texas. Diagn Microbiol Infect Dis 2011; 69(2):234-5.
Hirsch EB, Tam VH. Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes. Exp Rev Pharmacoecon Outcomes Res 2010; 10(4):441-51.
Palmer HR, Cottreau JM, Garey KG, Hirsch EB, Musick WL, Tam VH, Yeh RF, on behalf of the Houston Infectious Diseases Network. Significant publications on infectious diseases pharmacotherapy in 2009. Am J Health Syst Pharm 2010;67(15): e34-42.
Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infections. J Antimicrob Chemother 2010; 65(6):1119-25.
Kuper K, Hirsch EB, Tam VH, on behalf of the Houston Infectious Diseases Network. Significant publications on infectious diseases pharmacotherapy in 2008. Am J Health Syst Pharm 2009; 66(19): 1726-34.